DNA binding and bridging by human CtIP in the healthy and diseased states

TL;DR

This study explores how the human protein CtIP binds and bridges DNA, and how mutations linked to certain diseases affect these functions.

Contribution

The study identifies a DNA-binding domain in CtIP and shows that DNA bridging requires tetramerization, with implications for DNA repair.

Findings

CtIP binds non-specifically to DNA and can diffuse over long distances.

DNA bridging by CtIP requires tetramerization via the N-terminal domain.

Disease-associated CtIP variants show impaired DNA binding and bridging.

Abstract

The human DNA repair factor CtIP helps to initiate the resection of double-stranded DNA breaks for repair by homologous recombination, in part through its ability to bind and bridge DNA molecules. However, CtIP is a natively disordered protein that bears no apparent similarity to other DNA-binding proteins and so the structural basis for these activities remains unclear. In this work, we have used bulk DNA binding, single molecule tracking, and DNA bridging assays to study wild-type and variant CtIP proteins to better define the DNA binding domains and the effects of mutations associated with inherited human disease. Our work identifies a monomeric DNA-binding domain in the C-terminal region of CtIP. CtIP binds non-specifically to DNA and can diffuse over thousands of nucleotides. CtIP-mediated bridging of distant DNA segments is observed in single-molecule magnetic tweezers experiments. However, we show that binding alone is insufficient for DNA bridging, which also requires tetramerization via the N-terminal domain. Variant CtIP proteins associated with Seckel and Jawad syndromes display impaired DNA binding and bridging activities. The significance of these findings in the context of facilitating DNA break repair is discussed.

Graphical Abstract

Figures